Lilly 2Q Revenues: $3.9 billion (+5%) 2Q Earnings: $822 million (loss of $252 million 2Q2005)* YTD Revenues: $7.6 billion (+6%) YTD Earnings: $1.7 billion (earnings were $484.6 million YTD2005) Comments: Sales increase for the quarter was driven by the company’s newer products and accelerating sales of Cymbalta, up 92% to $310.4 million. Newer products–Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve–collectively grew 48% t...